Leucadia National Corporation »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 1.1M 0.94
2023-12-31 $792k 805k 0.98

More positions owned by Leucadia National Corporation

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Walt Disney Company (DIS)
Spdr Gold Tr Gold Shs (GLD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Russell 2000 Etf (IWM)
Delta Air Lines Inc Del Com New (DAL)
Visa Com Cl A (V)
Uber Technologies (UBER)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Micron Technology (MU)
Spdr Ser Tr S&p Biotech (XBI)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Hillman Solutions Corp (HLMN)

View all positions for Leucadia National Corporation

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Calamos Advisors
Opti Capital Management
Steelhead Partners
Aequim Alternative Investments
Citadel Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Readystate Asset Management
D. E. Shaw & Co
Zazove Associates
Shenkman Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1